Anesthesia Drugs Market from 2011 to 2015 - U.S. Market Entry Study

1
MarketsandMarkets Presents
Anesthesia Drugs Market in U.S. worth 7 Billion
by 2015
2
The Anesthesia Drugs Market (2011 - 2015) - U.S.
Market Entry Study analyzes and studies the U.S.
market for intravenous anesthesia drugs with
special focus on ketamine, distribution structure
of anesthesia drugs in U.S., potential buyers,
export import system for controlled substances
in U.S. and U.S. market entry strategy. Browse
market data tables and in-depth TOC of
Anesthesia Drugs Market (2011 - 2015) - U.S.
Market Entry Study. http//www.marketsandmarkets
.com/Market-Reports/anesthesia-drugs-ketamine-mark
et-713.html This report studies the U.S.
Ketamine market over the period of 2007-2015.
Ketamine market is expected to grow at a moderate
rate from 2011 to 2016. Anesthesia is a condition
in which sensation is totally or partially
blocked. This enables the patients to undergo
medical procedures and surgery.
3

• General anesthesia includes blockage of pain,
  awareness, and memory. Advantages offered by
  general anesthesia includes - rapid onset of
  anesthesia, full control of the body processes
  (airway, respiratory and circulatory system),
  used in surgeries with unpredictable duration of
  surgery, no memory of the surgery, allows
  complete motionlessness over prolonged duration
  of the surgery and it permits simultaneous
  operation on different body parts.
• General anesthesia drugs involve inhalation and
  intravenous anesthesia drugs. Report is specially
  focused on general intravenous anesthesia drugs
  category. Drugs such as propofol, midazolam
  diazepam, fospropofol disodium, sodium pentothal,
  ketamine, methohexital sodium, pentobarbital,
  etomidate, and fentanyl are studied.

4

• 3. The U.S. general anesthesia market size was
  approximately 2 billion in 2011 and is expected
  to grow at a moderate rate, with a CAGR of
  approximately 4 from 2011 to 2015. In addition,
  intravenous anesthetic drugs accounted for the
  largest share 65 of the U.S. general
  anesthetics drugs market in 2011.
• 4. Ketamine is an anesthetic drug mainly used
  for initiation and maintenance of general
  anesthesia in humans. It belongs to NMDA receptor
  antagonist class, which includes molecules that
  prevent the action of the N-methyl D-aspartate
  (NMDA) receptor. Factors such as increase in
  aging population, rising cardiovascular, and
  respiratory system related diseases and rising
  number of emergency surgeries will help in
  maintaining stable growth in the ketamine market
  revenue in the next five years along with the
  overall growth of the U.S. general intravenous
  anesthesia market.

5
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Blog http//twitter.com/marke
tsmarkets
http//www.linkedin.com/company/marketsandmarkets
6
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.